No Detail Found!

Physiological, Anatomical and Physicochemical Characteristics of Children Affecting Food-Drug Interaction-Review

Author(s)
Kamal Ali Attia Department of Biology, AlJamoum University College,Umm,Saudi ArabiaUniversity College, Umm Al-QuraUniversity,Al-Jamoum ,Saudi Arabia
Abstract
The drug-food interaction has a great interest in nutrition research to minimize unfavorable reactions to nutritional treatment. Failure tosupply appropriate nutrition to the child can harm both body developmentand growth. This review aimed to examine available data ontheimpact of diet on medication absorption in pediatric populations. Mechanismsunderlying food-drug interactions wereinvestigated to explore possible distinctions between adult and pediatric populations and to gain insight into how this may impact the pharmacokinetic profile in a child. Several changes in physiology, anatomy and physicochemical properties among children are likelyto result in food-drug interactions that cannot be anticipated based on adult studies. The influence of food on medications results in decreased bioavailability and altered drug elimination. Drugs, on the other hand, can affect dietary intake, digestion, absorption and excretion. Literature showsthat differencesin gastrointestinal physiologaynd anatomy between pediatric and adult populations can have amajor impact on drug absorption and bioavailability. A higher splanchnic blood flow may result in decreased drug bioavailability due toincreased lossinfirst-pass metabolism.To overcomtehe overall lack of knowledge onanalyzing food-drug interactions among pediatric populations, comprehensive procedures and recommendations must be developed.
Publication Details
Page(s) 1-7
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Children, Children, Children, Physicochemical, Paediatric physiology, paediatric anatomy, Interaction-Review, food-drug interaction
References
Hornsby LB,Hesterand A.R. Donaldson EK .2008 .Potential interaction between warfarin and high dietary proteinintake. , : .
Pharmacotherapy . .. , 28 : 536-539.
Ekincioglu A.B.and K.,Demirkan A.B.and K. .2013 .Clinical nutrition and drug interactions. Turk. J. Surg., 29 : 177-186.
Boullata JI. .2012 .Drug-nutrient interactions: A broad view with implications for practice. and LM. Hudson, : .
Acad J. . .. , 112 : 506-517.
Péter S,CB.van A. .2017 .Public health relevance of drug-nutrition interactions. Eur. J. Nutr, 56 : 23-36.
Reiss AMM .2014 .. , : .
. .Prevalence and clinical significance of drug-enteral nutritioniInntentsiveerCaraecUnitts. iBorazn.Nsursi. nMag., 67 : 85-90.
Chan LN .2013 .Drug-nutrient interactions. J. Parenteral Enteral Nutr, 37 : 450-459.
Karadima C.,Kraniotou G.T.,Tsangaris G.T. .2016 .Drug-micronutrient interactions: Food for thought and thought for action. EPMA J, 7 : .
Santos S.,LF.D. K.B.N.T.,Barros and R.M. da Silva Prado .2018 .. , : .
. .Interactions between drugs and nutrients: Occurrence and clinical management. J. Med. Biol. Sci., 17 : 65-70.
Mohn E.,Saltzman S.H.,Mitmesser S.H.,D.L.McKay S.H. .2018 .Evidence of drug-nutrient interactionwisth chronic use of commonly prescribed medications: An update. , : .
Pharmaceutics . .. , 10 : .
Schmidt K.,Dalhoff K. .2002 .Food-drug interactions. , : .
Drugs . .. , 62 : 1481-1502.
Ogbonna A.C.,C.M. Osuji A.C. .2015 .Functional components and medicinal properties of food: A review. , : .
Sci J.Food . .. , 52 : 2522-2529.
Adiwidjaja J.,Boddy A.V. .2017 .Curcumin asalinically-promising anti-canceragent: Pharmacokinetics and drug interactions. Expert Opin. Drug Metab. Toxicol., 13 : 953-972.
Bahramsoltani R .2017 .. , : .
. .Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J. Ethnopharmacol, 209 : 1-12.
Chalet C,Augustijns P. .2018 .Intestinal disposition of quercetinand its phase-Il metabolites after oral administration in healthy volunteers. J. Pharm. Pharmacol, 70 : 1002-1008.
Demirkan K,Bayraktar-Ekincioglu M.,Abbasoglu M. .2017 .Assessment of drug administration via feeding tube and the knowledge of health-care professionals ina university hospital. Eur. J. Clin. Nutr, 71 : 164-168.
Liu Q,Cherstniakova S.A.,S. S.A. .2012 .Common deficiencies with bioequivalence submissions in abbreviated new drug applications assessed by FDA. , 14 : 19-22.
Fritz A,Busch D.,Lapczuk J.,Ostrowski M.,Drozdzik M.,Oswald S. .2019 .Expression of clinically relevant drugmetabolizing enzymesalong the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis. Basic Clin. Pharmacol, 124 : 245-255.
Bushra R,Aslam N.,Khan A. .2011 .Food drug interactions. Oman Med, 26 : 77-83.
Koziolek S.,Alcaro M.,Grimm M. .2019 .The mechanisms of pharmacokinetic food-drugi npertspeectriveafcrotmtihe oUnNGAsP-grAoup.. , : .
Pharm Eur. J. . .. , 134 : 31-59.
WHO .1998 .Complementary Feeding of Young Children in Developing Countries: A Review of Current Scientific knowledge. , : 228.
Francis D.EM .1986 .Nutrition for Children. Blackwell Scientific, 9780632014781 : 164.
Kossena G.A.,Charman W.N.,Wilson C.G.,'Mahony B. O,B.Lindsay etal B. O .2007 .Low dose lipid formulations: Effects on gastric emptying and biliary secretion. Pharm. Res., 24 : 2084-2096.
Kaye J.L .2011 .Review of paediatric gastrointestinal physiology data relevant to oral drug delivery. Int. J. Clin., : .
Pharm . .. , 33 : 20-24.
Ehmann F,Aerssens J.,Blanchard R. .2020 .Commentary on ICH guideline on genomic sampling and data management-enabling opportunities in drug development and patient treatment. Br. J. Clin. Pharmacol, 86 : 1454-1464.
Little T.J,Gopinath A.,Patel E.,Mcglone A.,DJ. Lassman A. .2010 .Gastric emptying of hexose sugars: Role of osmolality, molecular structure and the CCK, receptor. , : .
Motil Neurogastroenterology . .. , 22 : 1183-1190.
Osuala EC,Tlou B.,Ojewole E.B. .2021 .Assessment of knowledge of drug-food interactions among healthcare professionals in public sector hospitals in eThekwini, KwaZulu-Natal. PLoS ONE, 16 : .
. .. , 0259402 : .
Zawiah M.,AM M.,AL-Ashwal A.,Matar A. .2020 .Food-drug interactions: Knowledge among pharmacists in Jordan. PLoS ONE, 15 : .
. .. , 0234779 : .
Ased S. .2018 .. , : .
. .Clinically significant food-drug interactions. Consultant Pharmacist®, 33 : 649-657.
Almazrou SH. .2022 .Knowledge and readiness for interprofessional learning among pharmacy and clinical nutrition students. and SS. Alaujan, : .
Multidiscip J. . .. , 15 : 1965-1970.
D'Alessandro C,Benedetti C,Paolo D.,Giannese A.,Cupisti A. .2022 .Interactions between food and drugs, and nutritional status in renal patients: A narrative review. , : .
Nutrients . .. , 14 : .
Spanakis M.,Melissourgaki M.,Patelarou E. .2021 .Prevalaendnclcineical significance of drug-drug and drug-dietary supplementinteractiaomonnsg patients admitted for cardiothoracic surgery in Greece.. , : .
Pharmaceutics . .. , 13 : .
Radwan A,Sweileh A.,Shraim W.,Hroub A.,Elaraj J.,Shraim N. .2018 .Evaluation of community pharmacists knowledge and awareness of food-drug interactions in Palestine. Int. J. Clin. Pharm, 40 : 668-675.
Osuala EC,Tlou B. .2022 .Knowledge, attitudes, and practices towards drug-food interactions among patients at public hospitals in eThekwini, KwaZuluNatal. , 22 : 681-690.
Debus J.L,Frahm N.,P. N. .2022 .Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis. Ther. Adv. Chronic Dis., 13 : .
Agbabiaka TB,Spencer N.H.,Khanom S.,Goodman C. .2018 .Prevalence of drug-herb and drug-supplement interactions in older adults: A cross-sectional survey. , : .
Gen Br. J. . .. , 68 : e711-e717.
Voigt N.,Ort K.,Sossalla S. .2019 .Drug-drug interactions you should know! Dtsch. , 144 : 264-275.
Neuvonen P.J. .1991 .The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac. , : .
Clin Br.J. . .. , 31 : 263-266.
Nicklas T.A.,C.E. O'Neil and VL. Fulgoni T.A. .2010 .Consumption of various forms of apples is associated with a better nutrient intake and improved nutrient adequacy in diets of children: National Health and Nutrition Examination Survey 2003-. , : .
Nutr Food . .. , 59 : 25948.
Allen LV,Mclaury HJ.,Sylvestri M.F. .1995 .Stability of ramipril in water, apple juice, and applesauce. Am. J. Health-Syst. Pharm., 52 : 2433-2436.
Patejdl R. .2017 .Spastimucltiiplte ysclieronsis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. , : .
Rev Autoimmunity . .. , 16 : 925-936.
Rommer P.S. .2018 .Managing the side effects of multiple sclerosis therapy: Pharmacotherapy options for patients. Expert Opin, 19 : 483-498.
Rommer P. .2022 .Treatment options in multiple sclerosis and neuromyelitis optica spectrum disorders. Curr. Pharm. Des., 28 : 428-436.
Wiendl H,Derfuss T.,Linker R. .2021 .Multiple sclerosis therapy consensus group (MSTCG): Position statement on disease-modifying therapies for multiple sclerosis (white paper). Ther. Adv. Neurol. Disord., 14 : .
Marrie RA .2019 .Comorbidity in multiple sclerosis: Past, present and future. Clin. Invest. Med, 42 : E5-E12.
Petersen M.J,Bergien D.,Staerk D. .2021 .A systematic review of possible interactions for herbal medicines and dietary supplements used concomitantly with diseasemodifying or symptom-alleviating multiple sclerosis drugs. , : .
Phytother. Res. . .. , 35 : 3610-3631.
Rommer P.S.,Kénig N.,A. N. .2018 .Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study. , : .
Neurosci. Ther CNS . .. , 24 : 784-789.
Gotta M.,Huebner J. .2018 .Use of complementary and alternative medicine in patients with multiple sclerosis in Germany. Complementary Ther. Med, 36 : 113-117.
Frahm N.,Hecker M.,Langhorst S.E.,Mashhadiakbar P. .2020 .The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis. Ther. Adv. Neurol., : .
Disord . .. , 13 : .
Batchelor HK .2015 .Influence of food on paediatric gastrointestinal ~ drug absorption following oral administration: A review. Children, 2 : 244-271.
0

Citations

0

Downloads

38

Views